Loading...
GENT logo

Gentian Diagnostics Community

OB:GENT Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

Community Investing Ideas

GENT logo
Gentian Diagnostics

Expanding Into $18 Billion Diagnostics Market Will Boost Prospects Despite Potential Risks

Key Takeaways Expansion of PETIA technology and product portfolio is anticipated to drive substantial future revenue and earnings growth. Strategic contract acquisitions and market expansion for key products are expected to enhance revenues, margins, and overall profitability.Read more

View narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
NOK 67
18.8% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
34.44% p.a.
Profit Margin
9.04%
Future PE
34.11x
Share price in 2028
NOK 79.36